We are live on
!
Find out more
DM
Deerfield Management Portfolio holdings
AUM
$8.48B
1-Year Est. Return
99.04%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.51B
AUM Growth
+$445M
(+8.8%)
Cap. Flow
-$338M
Cap. Flow
% of AUM
-6.13%
Top 10 Holdings %
Top 10 Hldgs %
54.24%
Holding
167
New
43
Increased
28
Reduced
13
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$79.3M |
| 2 |
Merck
MRK
|
+$68.2M |
| 3 |
Vera Therapeutics
VERA
|
+$51.7M |
| 4 |
Legend Biotech
LEGN
|
+$39.5M |
| 5 |
Centene
CNC
|
+$30.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alignment Healthcare
ALHC
|
+$68M |
| 2 |
DVAX
Dynavax Technologies
DVAX
|
+$67.3M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$36.8M |
| 4 |
CMRX
Chimerix, Inc.
CMRX
|
+$32.1M |
| 5 |
InMode
INMD
|
+$28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.05% |
| 2 | Real Estate | 0.41% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Sotera Health
SHC
$5.06B
| $503K | 0.01% |
+45,242
| New | +$530K |
|
77
Cooper Companies
COO
$14B
| $450K | 0.01% |
+6,328
| New | +$485K |
|
78
Thermo Fisher Scientific
TMO
$198B
| $371K | 0.01% |
+916
| New | +$383K |
|
79
UFP Technologies
UFPT
$1.87B
| $370K | 0.01% |
+1,517
| New | +$341K |
|
80
Align Technology
ALGN
$12.7B
| $368K | 0.01% |
+1,945
| New | +$344K |
|
81
AtriCure
ATRC
$1.77B
| $365K | 0.01% |
+11,138
| New | +$362K |
|
82
LeMaitre Vascular
LMAT
$2.32B
| $346K | 0.01% |
+4,169
| New | +$348K |
|
83
OrthoPediatrics
KIDS
$493M
| $333K | 0.01% |
+15,486
| New | +$335K |
|
84
Enovis
ENOV
$1.56B
| $322K | 0.01% |
+10,267
| New | +$340K |
|
85
National Healthcare
NHC
$3.56B
| $313K | 0.01% |
+2,926
| New | +$292K |
|
86
DaVita
DVA
$15.2B
| $299K | 0.01% |
+2,101
| New | +$298K |
|
87
BioLife Solutions
BLFS
$1.42B
| $294K | 0.01% |
+13,670
| New | +$308K |
|
88
Universal Health Services
UHS
$9.15B
| $289K | 0.01% |
+1,597
| New | +$288K |
|
|
AMED
89
DELISTED
Amedisys
AMED
| $270K | ﹤0.01% |
+2,744
| New | +$260K |
|
90
Haemonetics
HAE
$3.54B
| $263K | ﹤0.01% |
+3,529
| New | +$234K |
|
91
IQVIA
IQV
$34.4B
| $256K | ﹤0.01% |
+1,623
| New | +$244K |
|
92
MiMedx Group
MDXG
$640M
| $240K | ﹤0.01% |
+39,351
| New | +$262K |
|
93
Medpace
MEDP
$15.4B
| $231K | ﹤0.01% |
+736
| New | +$221K |
|
94
Humana
HUM
$48B
| $224K | ﹤0.01% |
917
| – | – |
|
95
Amphastar Pharmaceuticals
AMPH
$871M
| $220K | ﹤0.01% |
+9,579
| New | +$238K |
|
|
QSIAW
96
DELISTED
Quantum-Si Inc Warrant
QSIAW
| $217K | ﹤0.01% |
333,333
| – | – |
|
97
Teleflex
TFX
$5.96B
| $214K | ﹤0.01% |
+1,805
| New | +$228K |
|
98
CorVel
CRVL
$3.15B
| $205K | ﹤0.01% |
+1,993
| New | +$220K |
|
99
Zoetis
ZTS
$32.1B
| $204K | ﹤0.01% |
+1,310
| New | +$208K |
|
100
Repligen
RGEN
$8.31B
| $202K | ﹤0.01% |
+1,628
| New | +$207K |
|
Similar funds
FT
GRQ
AV
PCM
VA
QC
IC
NW
Deerfield Management's Q2 2025 Portfolio in Review
As of Q2 2025, Deerfield Management held 167 positions worth $5.51B, up 8.8% from $5.06B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Deerfield Management withdrew a net $338M in Q2 2025, closing 43 positions and reducing 13 holdings. Its most notable exit was Dynavax Technologies, an estimated $67.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 87% a quarter earlier, followed by Real Estate and Financials.
Against the trend, Deerfield Management opened a new position in Merck worth $67.9M.
- Deerfield Management's largest Q2 2025 buy was Merck: 857,724 shares worth $67.9M.
- Deerfield Management added most to United Therapeutics in Q2 2025, an estimated $79.3M increase.
- Deerfield Management's biggest Q2 2025 reduction was Alignment Healthcare, cutting an estimated $68M.
- Deerfield Management fully exited Dynavax Technologies in Q2 2025, selling an estimated $67.3M.
- Deerfield Management's ten largest holdings make up 54% of its $5.51B portfolio in Q2 2025.
- Deerfield Management opened 43 new positions and closed 43 in Q2 2025.
- Deerfield Management's portfolio value rose 8.8% quarter-over-quarter to $5.51B.
Based on Deerfield Management's 13F filing for Q2 2025, filed 14 Aug 2025.